Get started
VAXART INCVAXART INCVAXART INC

VAXART INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

VXRT chart


Full chart

VXRT upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.25 B‬ MXN
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−5.57 MXN
Net income (FY)
‪−1.40 B‬ MXN
Revenue (FY)
‪598.38 M‬ MXN
Shares float
‪222.59 M‬
Beta (1Y)
2.14

Employees


Employees (FY)
115
Change (1Y)
−10 −8.00%
Revenue / Employee (1Y)
‪5.20 M‬ MXN
Net income / Employee (1Y)
‪−12.14 M‬ MXN

About Vaxart, Inc. - Common Stock


Sector
Health Technology
Industry
Biotechnology
CEO
Steven Lo
Website
vaxart.com
Headquarters
South San Francisco
Founded
2004
FIGI
BBG00Z844DB0
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV). The company was founded by Sean Tucker in March 2004 and is headquartered in South San Francisco, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

VXRT news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as VXRT.

Frequently Asked Questions


The current price of VXRT is 12.00 MXN — it hasn't changed in the past 24 hours. Watch VAXART INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange VAXART INC stocks are traded under the ticker VXRT.
We've gathered analysts' opinions on VAXART INC future price: according to them, VXRT price has a max estimate of 160.68 MXN and a min estimate of 40.17 MXN. Watch VXRT chart and read a more detailed VAXART INC stock forecast: see what analysts think of VAXART INC and suggest that you do with its stocks.
VXRT reached its all-time high on Apr 30, 2021 with the price of 225.00 MXN, and its all-time low was 10.00 MXN and was reached on Jun 17, 2024. View more price dynamics on VXRT chart.
See other stocks reaching their highest and lowest prices.
VXRT stock is 0.00% volatile and has beta coefficient of 2.14. Track VAXART INC stock price on the chart and check out the list of the most volatile stocks — is VAXART INC there?
Today VAXART INC has the market capitalization of ‪2.25 B‬, it has decreased by −3.53% over the last week.
Yes, you can track VAXART INC financials in yearly and quarterly reports right on TradingView.
VAXART INC is going to release the next earnings report on Aug 7, 2025. Keep track of upcoming events with our Earnings Calendar.
VXRT earnings for the last quarter are −1.43 MXN per share, whereas the estimation was −1.98 MXN resulting in a 27.59% surprise. The estimated earnings for the next quarter are −1.69 MXN per share. See more details about VAXART INC earnings.
VAXART INC revenue for the last quarter amounts to ‪427.69 M‬ MXN, despite the estimated figure of ‪58.39 M‬ MXN. In the next quarter, revenue is expected to reach ‪21.19 M‬ MXN.
VXRT net income for the last quarter is ‪−319.42 M‬ MXN, while the quarter before that showed ‪−249.88 M‬ MXN of net income which accounts for −27.83% change. Track more VAXART INC financial stats to get the full picture.
No, VXRT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 19, 2025, the company has 115 employees. See our rating of the largest employees — is VAXART INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VAXART INC EBITDA is ‪−1.08 B‬ MXN, and current EBITDA margin is −215.66%. See more stats in VAXART INC financial statements.
Like other stocks, VXRT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VAXART INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VAXART INC technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VAXART INC stock shows the sell signal. See more of VAXART INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.